Quarterly Call Option Transactions in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP) during . The information is specifically focused on institutions that hold call options of Adaptimmune Therapeutics PLC.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 7,400 | 0 | 7,400 | 7,600 | 0 | 7,600 | -200 | |
| Q4 2021 | 3,000 | 10,000 | 13,000 | 1,000 | 0 | 1,000 | 12,000 | |
| Q1 2022 | — | 0 | 15,100 | 15,100 | -15,100 | |||
| Q2 2022 | — | — | 0 | |||||
| Q3 2022 | — | 36,500 | 0 | 36,500 | -36,500 | |||
| Q4 2022 | — | 11,000 | 0 | 11,000 | -11,000 | |||
| Q1 2023 | — | 1,100 | 0 | 1,100 | -1,100 | |||
| Q2 2023 | — | 3,825 | 0 | 3,825 | -3,825 | |||
| Q3 2023 | — | 5,775 | 0 | 5,775 | -5,775 | |||
| Q4 2023 | — | — | 0 | |||||
| Q1 2024 | 0 | 42,800 | 42,800 | — | 42,800 | |||
| Q2 2024 | 24,000 | 11,700 | 35,700 | — | 35,700 | |||
| Q3 2024 | 21,000 | 0 | 21,000 | 38,700 | 0 | 38,700 | -17,700 | |